Dummy Account

Brighter Presents at Medtech Investment Day Scandinavia in Stockholm

Wed, Sep 07, 2011 12:09 CET

During an all day event, organized by the Nordic medtech industry organizations, leading institutional and private investors are brought together with carefully selected companies of the future. Medtech Investment Day Scandinavia , taking off at September 8, brings together Scandinavian medtech firms that seek partnerships or expansion capital with venture capitalists, business angels, and private and industrial investors. The event also provides an excellent opportunity to increase business networks in

Massive Demand – Extended IPO Period

Wed, Aug 24, 2011 11:53 CET

The demand from patient organizations and relatives to get Brighter One™ demonstrated has by far surpassed Brighter’s expectations. Since the company wishes to spread the information about the company and Brighter OneTM as broadly as possibly, the board decided to extend the issuing period until September 26. “The response we have received is fantastic and an extension serves a dual purpose. On the one hand, we get to meet more interested investors, but above all, we get a splendid chance to demonstrate Brighter One for those who will actually use it” says Truls Sjöstedt, CEO.

Founders Increase Their Shareholding

Mon, Aug 22, 2011 22:54 CET

Before the IPO of Swedish medtech company Brighter AB (publ) was launched, the founders, Michael Frantzén and Truls Sjöstedt , increased their shareholding by a total of 875 000 shares in Brighter, corresponding to 8.74% of the total capital stock (437 500 shares and 4.37% respectively).”The acquisition is to be seen as a sign of our long-term belief in the company that we have founded, and in the future, before which Brighter stands with an upcoming commercialization of Brighter One, the market’s first

Brighter Sheds Light on the Darkness of the Stock Markets

Mon, Aug 22, 2011 07:01 CET

In the middle of one of the darkest periods on the stock markets, medtech company Brighter AB (publ) invites to its IPO at AktieTorget with the purpose to attract 8.5 MSEK. The executive board shines with stable optimism despite the darkness of the stock market. With the main patent approved one year earlier than planned, Brighter leaves the period as a pure development company and goes on to producing and commercializing the product portfolio Brighter OneTM , an attractive world news with great global potential.”Through combining existing techniques,

Brighter Has Launched Its Initial Public Offering Period

Sat, Aug 20, 2011 14:56 CET

Brighter AB (publ) has launched its Initial Public Offering period at AktieTorget as promised. The company has developed and patented the world’s first all-in-one self-care device for diabetics that does not need to be attached to the body: Brighter One TM . Now, the public is offered a unique opportunity to take part in Brighter’s future growth through the IPO.After the listing, Brighter plans to complete the production plants that are required to start the production of the company’s patented self-care systems. These compose a production series that will